United Capital Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
17,240
+2,025
| +13% | +$30.4K | ﹤0.01% | 963 |
|
|
2025
Q1 | $201K | Buy |
15,215
+601
| +4% | +$7.93K | ﹤0.01% | 1009 |
|
|
2024
Q4 | $231K | Buy |
14,614
+149
| +1% | +$2.35K | ﹤0.01% | 967 |
|
|
2024
Q3 | $230K | Buy |
+14,465
| New | +$230K | ﹤0.01% | 962 |
|
|
2021
Q1 | – | Sell |
-97,980
| Closed | -$1.4M | – | 1220 |
|
|
2020
Q4 | $1.4M | Sell |
97,980
-22,745
| -19% | -$324K | 0.01% | 585 |
|
|
2020
Q3 | $1.68M | Buy |
+120,725
| New | +$1.68M | 0.01% | 542 |
|
|
2018
Q1 | – | Sell |
-286,045
| Closed | -$2.15M | – | 1352 |
|
|
2017
Q4 | $2.15M | Buy |
286,045
+2,945
| +1% | +$22.1K | 0.02% | 570 |
|
|
2017
Q3 | $2.02M | Buy |
283,100
+29,515
| +12% | +$211K | 0.02% | 569 |
|
|
2017
Q2 | $2.14M | Sell |
253,585
-12,250
| -5% | -$103K | 0.02% | 552 |
|
|
2017
Q1 | $2.14M | Buy |
265,835
+29,815
| +13% | +$239K | 0.02% | 551 |
|
|
2016
Q4 | $2.14M | Buy |
236,020
+10,610
| +5% | +$96.1K | 0.02% | 553 |
|
|
2016
Q3 | $2.09M | Buy |
+225,410
| New | +$2.09M | 0.02% | 574 |
|
|
2016
Q1 | – | Sell |
-291,030
| Closed | -$2.69M | – | 1264 |
|
|
2015
Q4 | $2.69M | Buy |
291,030
+204,485
| +236% | +$1.89M | 0.03% | 487 |
|
|
2015
Q3 | $1.11M | Hold |
86,545
| – | – | 0.01% | 663 |
|
|
2015
Q2 | $958K | Buy |
86,545
+920
| +1% | +$10.2K | 0.01% | 729 |
|
|
2015
Q1 | $890K | Hold |
85,625
| – | – | 0.01% | 748 |
|
|
2014
Q4 | $864K | Buy |
85,625
+175
| +0.2% | +$1.77K | 0.01% | 686 |
|
|
2014
Q3 | $898K | Hold |
85,450
| – | – | 0.02% | 632 |
|
|
2014
Q2 | $737K | Buy |
85,450
+9,480
| +12% | +$81.8K | 0.01% | 618 |
|
|
2014
Q1 | $667K | Buy |
+75,970
| New | +$667K | 0.01% | 577 |
|